首頁
Circassia

7月 2026Circassia的市場佔有率分析

Our ‘FeNO by NIOX®’ range helps physicians around the world see airway inflammation clearly, helping improve asthma diagnosis and management.

健康 > 生物技術和製藥

域名circassia.com

成立年份2006

僱員201 - 500

年度營收$25M - $50M

Circassia

Circassia（包含公司地區）

circassia.com

查看更多網站流量與參與度資訊

Circassia截至 7月 2026 的總收入為 25M - 50M

Circassia 熱門網域產生的總收入

Circassia 熱門網域 3 年內的總收入

Circassia 熱門網域的總收入

circassia.com25M - 50M

透過銷售情報查看更多內容

Circassia的熱門網域總造訪量

了解Circassia市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Circassia的熱門網域平均造訪時長

分析Circassia參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Circassia的熱門網域平均頁面瀏覽量

了解Circassia如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Circassia按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Circassia

这些是Circassia顶级域名使用的行业网站技术

付費廣告 (2)

DoubleClick

市場行銷 (2)

Google Marketing Platform

行動裝置 (2)

Meta Viewport

招募 (2)

Applicant Pro

更多技術

10

檢視所有

新聞與訊號來自Circassia

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Circassia Pharmaceuticals plc launched Niox Vero nasal mode in Europe for screening the primary ciliary dyskinesia on Sep 1st '17.UK based company, Circassia launched Niox Vero nasal mode in Europe for screening the primary ciliary dyskinesia in September 2017.

新聞Circassia Pharmaceuticals plc hired Garry Watts as senior independent director on Mar 2nd '20.Circassia Pharmaceuticals PLC ( LON:CIR ), a specialty pharmaceutical company focused on respiratory disease, has confirmed the proposed appointment of Garry Watts to the Board as a senior independent director with effect from 2 March 2020.

新聞Circassia Pharmaceuticals plc hires Michael Roller as chief financial officer.Circassia also announced the appointment of Michael Roller as chief financial officer to replace Julien Cotta, who has stepped down after eight years in the role.